Therapeutic Antibody Discovery: Selecting Effective Candidates for Emerging Viral Threats
Featured Speakers: Robert Carnahan, PhD, Associate Director, Vanderbilt Vaccine Center | Lauren Williamson, PhD, Research Assistant Professor, Vanderbilt University
Methods for rapidly isolating and characterizing human monoclonal antibodies targeting the SARS-CoV-2 spike protein
Scientific challenges of targeting diverse viral strains and the role of broad-spectrum antibodies, such as AstraZeneca’s Evusheld, in addressing viral variants
Achievements in the pandemic preparedness platform development to develop highly potent monoclonal antibodies against current and future viral threats
